GlassScriptPhysician profile
Andrea Green
NPI 1356328231
$1,531.88
in general payments reported to CMS, 2019-2025
12 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $591 · 2022: $386 · 2023: $263 · 2024: $30.09 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $670.10 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.12 | 2022-2023 | Lifevest |
| Penumbra, INC. | $152.07 | 2025 | Penumbra System |
| Astellas Pharma US INC | $125.00 | 2023 | Cresemba |
| E.R. Squibb & Sons, L.L.C. | $118.84 | 2022 | |
| Novartis Pharmaceuticals Corporation | $94.25 | 2025 | |
| Amgen INC. | $78.19 | 2021-2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $39.81 | 2021 | |
| Pfizer INC. | $30.09 | 2024 | |
| Emd Serono, INC. | $23.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.84 | 2025 | Jardiance |
| Boston Scientific Corporation | $13.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.